CenExel partners with Alzheimer's Association for virtual event
The free session on October 13 educates attendees about warning signs and discusses current clinical research studies for dementia.
See the latest news and media coverage for CenExel. We track all announcements, press releases, and industry mentions in real time, all in one place.
Clinical research site network
cenexel.comLast updated
In short: CenExel was acquired by BayPine, appointed new executive leadership, and supported the FDA approval of a non-opioid pain treatment.
The free session on October 13 educates attendees about warning signs and discusses current clinical research studies for dementia.
He joins with over 25 years of experience to lead technology and innovation efforts in clinical research.
Nearly 80% of non-US raters experience burnout, impacting data quality. Presented at ASCP meeting.
The EMERGENT-3 trial met its primary endpoint with an 8.4-point PANSS reduction versus placebo, supporting a new muscarinic antipsychotic class.
“Finding patients for pharma companies and getting them into the trial as quickly as possible is really a key need that these companies are willing...
BayPine LP (“BayPine”), a private investment firm that drives digital transformation in market-leading businesses, today announced that it has entered into a...
(MENAFN- GlobeNewsWire - Nasdaq) Salt Lake City, UT, July 17, 2023 (GLOBE NEWSWIRE) -- The cenexel Board of Directors is delighted to announce that Stuart...
Salt Lake City, Utah, May 03, 2022 (GLOBE NEWSWIRE) -- CenExel announces the acquisition of iResearch ("CenExel iResearch"), a leading multi-specialty research site business with...
Track CenExel and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to CenExel and other trending companies.